Are we Close Enough to get rid of AIDS: Insights in to Impact of Human Immunodeficiency Virus (HIV) Infection Post Highly Active Antiretroviral Therapy (HAART) Era.
K.V. Ramana, PhD
Department of Microbiology, Prathima Institute of Medical sciences, Karimnagar, Andhrapradesh, India
International Journal of Molecular Medical Science, 2013, Vol. 3, No. 4 doi: 10.5376/ijmms.2013.03.0004
Received: 18 Mar., 2013 Accepted: 03 Apr., 2013 Published: 17 Jun., 2013
© 2013 BioPublisher Publishing Platform
This is an open access article published under the terms of the Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Preferred citation for this article:
Ramana, 2013, Are We Close Enough to get rid of Aids: Insights in to Impact of Human Immunodeficiency Virus (HIV) Infection Post highly Active Antiretroviral Therapy (HAART) Era., International Journal of Molecular Medical Science, Vol.3, No.4 25-29 (doi: 10.5376/ijmms.2013.03.0004)
Human Immunodeficiency Virus (HIV) is a retrovirus belonging to the Lentivirus group that also consists of Simian Immunodeficiency Virus (SIV) that causes AIDS in monkeys and have the ability to cause chronic infections. Previous studies have confirmed the occurrence of opportunistic infections (OI's) with bacteria, fungi, parasites and viruses in HIV infected individuals when CD4T+ cell counts fall below 200 cells/mm3. Studies have also highlighted the role of HIV infection in the development of carcinogenesis. Recently there have been many studies from around the globe establishing the role of HIV in the development of haematological, biochemical and metabolic disorders. Though a lot has improved in the laboratory diagnosis of HIV with the advent of newer generation detection methods, that considerably reduce window period, the cause of concern now is the effect of Highly Active Antiretroviral therapy (HAART), and the management of patients on HAART.
Human immunodeficiency virus (HIV); Highly active antiretroviral therapy (HAART); HIV disease management